Health
Jun 15, 2026
Unapproved Stem Cell Treatments for Autistic Children Promoted by US Health Secretary RFK Jr
Autistic children are receiving potentially harmful unapproved stem cell treatments promoted by US …
The Rise of Unregulated Stem Cell Treatments for Autism
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and potentially harmful "treatments" that scientists warn are proliferating across the US under the active encouragement of the US health secretary, Robert F Kennedy Jr.
Clinics in Florida, Texas and other states are selling what they bill as "regenerative medicine" to families with autistic children who have intensive care needs. Parents who have taken their children through the process talked about their hopes and fears for a therapy that appears to be gaining ground in the US.
The Mechanics of Questionable Stem Cell Procedures
The procedure, which can involve the child being sedated with ketamine before receiving intravenous doses of millions of stem cells, costs up to $20,000 for each treatment. Families are often advised to return for regular top-ups.
Profoundly stressed parents are being wooed to the clinics with promises that a high-dose infusion of umbilical cord stem cells can lead to dramatic improvements in their children's ability to speak, socialise, or avoid aggressive or self-harming behaviour. Yet there is no scientific evidence that the procedure works – the most comprehensive clinical trial staged so far, a placebo experiment conducted by Duke University, found insignificant benefits for most of the 180 children tested.
The US Food and Drug Administration (FDA) directly cautions parents that if they are being offered stem cell treatments outside an approved clinical trial, "you are likely being deceived and offered a product illegally".
Financial Impact of the Unregulated Treatment Market
The burgeoning market for unproven stem cell treatments represents a significant financial burden on families already dealing with the high costs of autism care. Treatments can cost up to $20,000 per session, with many providers recommending multiple treatments over time.
Among the providers is Better Stem, a Miami-based company run by Greice Murphy, which charges $300 for an initial consultation followed by up to $15,000 per infusion. The company claims to be the first in the US offering "legal, compliant access" to stem cell therapies under the "right-to-try" law, despite autism not meeting the legal definition of a terminal illness covered by that legislation.
Families like Taylor and her four-year-old son Ollie from Utah are raising funds through donations to cover the $12,500 cost of a single treatment, highlighting the desperate financial sacrifices parents are making for these unproven therapies.
Regulatory Erosion and Shifting Healthcare Landscape
In his 16 months as the secretary of the Department of Health and Human Services within the Trump administration, Kennedy has undercut established scientific endeavors. He has fired thousands of federal health officials, dismissed longstanding scientific advisers, defunded $31m in autism-related research and attempted to shrink the recommended list of childhood vaccinations.
At the same time, largely unnoticed, he has given his backing to alternative health providers moving to fill the gap. Kennedy appeared by video link at the first two annual summits held in San Diego by Autism Health, a leading advocate of stem cell infusions for autistic kids.
Those providers include Mike Chan, a Malaysian physician who presented the San Diego summit with a protocol that involves injecting autistic children in the buttocks with high doses of stem cells extracted from slaughtered sheep and rabbits.
Kennedy described the organiser of the San Diego summit, Tracy Slepcevic, as a "good friend" and appointed her to his remodelled Autism Coordinating Committee, which guides federally funded autism research.
Future Outlook for Autism Treatment Regulation
The proliferation of unproven stem cell treatments for autism appears likely to continue, with a new clinical trial planned to involve 120 autistic children in Mexico, a country that has historically taken a looser approach to stem cell regulation than the US.
Ed Clay, founder of the Cellular Performance Institute in Tijuana, said the clinical trial would be free to families and fully licensed under the Mexican federal health authority, Cofepris. He claimed his team includes "21 PhD scientists and 42 medical doctors, including PhDs from institutions such as Harvard, Yale, MIT and Stanford".
While Clay said the clinical trial could potentially be imported to US sites under full FDA licensing if early results are promising, other stem cell providers operating in this space may not hold such standards. Clay himself acknowledged: "I would say our biggest competitor right now for CPI is the scammer and the many fly-by-night clinics operating in this space."
Despite Kennedy's stated desire to prevent a "wild west" of alternative therapies, his administration's actions suggest a continued expansion of unregulated treatments, potentially leaving vulnerable families exposed to financial exploitation and medical risks without scientific validation.
#Robert F Kennedy Jr
#stem cell therapy
#autism
Read More